case_images: PMC10830838_01
case_images: Patient timeline.
case_images: fneur-14-1329541-g0001.jpg
case_images: PMC10830838_01_fneur-14-1329541-g0001.jpg
case_images: F1
case_images: Given the deteriorating symptoms, riluzole was offered but our patient declined, after which an 18-month time-restricted ketogenic diet (TRKD) was presented as an option (Figure 1).
case_images: Mean monthly blood glucose and ketone (beta-hydroxybutyrate) levels during the time-restricted ketogenic diet (TRKD). Error bars indicate standard error.
case_images: fneur-14-1329541-g0002.jpg
case_images: PMC10830838_01_fneur-14-1329541-g0002.jpg
case_images: F2
case_images: During the 18-month TRKD, our patient's mean blood glucose and ketone levels were 6.52 +/- 0.91 and 0.77 +/- 0.43 mmol/L, respectively (Figure 2), with improvement or stability documented in most outcome measures (Tables 1, 2).